| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Division of Cardiovascular and Medical Sciences (DJS, GDOL, AR, PL, and PWM), the Nursing & Midwifery School (GM), and the Robertson Centre for Biostatistics (ADM), University of Glasgow, Glasgow, United Kingdom; the Departments of Haematology (RCT) and Pathological Biochemistry (DSJO), Glasgow Royal Infirmary, Glasgow, United Kingdom; the Department of Geriatric Medicine, Garnavel General Hospital, Glasgow, United Kingdom (EGS and JBM); and the Section of Gerontology and Geriatrics, Leiden University Medical Centre, Leiden, Netherlands (RGJW)
Background: Homocysteine is an independent risk factor for vascular disease and is associated with dementia in older people. Potential mechanisms include altered endothelial and hemostatic function.
Objective: We aimed to determine the effects of folic acid plus vitamin B-12, riboflavin, and vitamin B-6 on homocysteine and cognitive function.
Design: This was a factorial 2 x 2 x 2, randomized, placebo-controlled, double-blind study with 3 active treatments: folic acid (2.5 mg) plus vitamin B-12 (500 µg), vitamin B-6 (25 mg), and riboflavin (25 mg). We studied 185 patients aged 
65 y with ischemic vascular disease. Outcome measures included plasma homocysteine, fibrinogen, and von Willebrand factor at 3 mo and cognitive change (determined with the use of the Letter Digit Coding Test and on the basis of the Telephone Interview of Cognitive Status) after 1 y.
Results: The mean (±SD) baseline plasma homocysteine concentration was 16.5 ± 6.4 µmol/L. This value was 5.0 (95% CI: 3.8, 6.2) µmol/L lower in patients given folic acid plus vitamin B-12 than in patients not given folic acid plus vitamin B-12 but did not change significantly with vitamin B-6 or riboflavin treatment. Homocysteine lowering with folic acid plus vitamin B-12 had no significant effect, relative to the 2 other treatments, on fibrinogen, von Willebrand factor, or cognitive performance as measured by the Letter Digit Coding Test (mean change: –1; 95% CI: –2.3, 1.4) and the Telephone Interview of Cognitive Status (–0.7; 95% CI: –1.7, 0.4).
Conclusion: Oral folic acid plus vitamin B-12 decreased homocysteine concentrations in elderly patients with vascular disease but was not associated with statistically significant beneficial effects on cognitive function over the short or medium term.
Key Words: Elderly • homocysteine • folic acid • vitamin B-12 • riboflavin • vitamin B-6 • randomized controlled trial • cognitive function
This article has been cited by other articles:
|
|
 |
|
  J. H. Kang, N. Cook, J. Manson, J. E Buring, C. M Albert, and F. Grodstein A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease Am. J. Clinical Nutrition, December 1, 2008; 88(6): 1602 - 1610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. P. J. den Elzen, R. G. J. Westendorp, M. Frolich, W. de Ruijter, W. J. J. Assendelft, and J. Gussekloo Vitamin B12 and Folate and the Risk of Anemia in Old Age: The Leiden 85-Plus Study Arch Intern Med, November 10, 2008; 168(20): 2238 - 2244. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Coley, S. Andrieu, V. Gardette, S. Gillette-Guyonnet, C. Sanz, B. Vellas, and A. Grand Dementia Prevention: Methodological Explanations for Inconsistent Results Epidemiol. Rev., November 1, 2008; 30(1): 35 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Clarke and D. A. Bennett B Vitamins for Prevention of Cognitive Decline: Insufficient Evidence to Justify Treatment JAMA, October 15, 2008; 300(15): 1819 - 1821. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ryan-Harshman and W. Aldoori Vitamin B12 and health Can Fam Physician, April 1, 2008; 54(4): 536 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S McCully Homocysteine, vitamins, and vascular disease prevention Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1563S - 1568S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kim, M. H. Park, E. Kim, C. Han, S. A. Jo, and I. Jo Plasma Homocysteine Is Associated with the Risk of Mild Cognitive Impairment in an Elderly Korean Population J. Nutr., September 1, 2007; 137(9): 2093 - 2097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Midttun, S. Hustad, J. Schneede, S. E Vollset, and P. M Ueland Plasma vitamin B-6 forms and their relation to transsulfuration metabolites in a large, population-based study Am. J. Clinical Nutrition, July 1, 2007; 86(1): 131 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. N Haan, J. W Miller, A. E Aiello, R. A Whitmer, W. J Jagust, D. M Mungas, L. H Allen, and R. Green Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging Am. J. Clinical Nutrition, February 1, 2007; 85(2): 511 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Balk, G. Raman, A. Tatsioni, M. Chung, J. Lau, and I. H. Rosenberg Vitamin B6, B12, and Folic Acid Supplementation and Cognitive Function: A Systematic Review of Randomized Trials Arch Intern Med, January 8, 2007; 167(1): 21 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J.M. de Craen, D. J. Stott, R. G.J. Westendorp, A. Khare, M. Lopez, J. Gogtay, E. P. Quinlivan, J. F. Gregory III, H. Refsum, A. D. Smith, et al. Homocysteine, B vitamins, and cardiovascular disease. N. Engl. J. Med., July 13, 2006; 355(2): 205 - 206. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
